Recombinant  Human Epidermal Growth Factor (EGF)

CAS.NO: 62253-63-8
The recombinant epidermal growth factor (EGF) is a biologically active protein factor for cell culture, a type of polypeptide substance widely present in mammals, which exerts a physiological action by binding to the EGF receptor on the cell membrane.
Recombinant EGF Application
Recombinant human epidermal growth factor(EGF) is a protein that has a wide range of applications in medical research and biotechnology. It is a naturally occurring protein that is essential for the normal development and maintenance of healthy skin cells. Recombinant Human EGF has been used in a variety of clinical applications, including wound healing, tissue regeneration, and skin rejuvenation.
Recombinant EGF can be used to stimulate cell growth and repair, and has been shown to promote the formation of new blood vessels, reduce inflammation, and increase the rate of wound healing. In addition, Recombinant Human EGF Protein has been used to stimulate the growth of skin tissues, such as hair follicles, collagen, and keratinocytes, and to promote the healing of traumatic wounds. Recombinant EGF is also being studied for its potential to treat a range of skin diseases and disorders, such as psoriasis and atopic dermatitis.

Recombinant Human EGF Recommended Method
Recombinant Human EGF (Epidermal Growth Factor) is a protein found in the human body that has been genetically engineered for research and therapeutic use. It has been used for a variety of applications, such as tissue engineering, regenerative medicine, and drug delivery systems. The recommended method for producing EGF Human Recombinant is through the use of bacteria or yeast as a host organism. These organisms are transformed with a recombinant DNA construct that contains the gene encoding for EGF.

The Recombinant EGF protein is then expressed and purified from the host organism. This method is advantageous because it can produce large amounts of the Recombinant Human EGF Protein in a short amount of time, while still maintaining its structure and function. Additionally, this method can be used to produce EGF Human Recombinant in a variety of different forms, such as monomeric or dimeric, to meet the needs of a particular application.

Gene Biocon, as an excellent biological pharma company, offers a wide range of Liraglutide for you to choose from.